New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
07:02 EDTBTHEBoston Therapeutics appoints Benjamin Rivnay, Ph.D. to Chief Scientist
Boston Therapeutics has appointed Benjamin Rivnay, Ph.D. to serve as its Chief Scientist, a newly created position. In this role, Dr. Rivnay will be responsible for the development of the company's science and technology. He will serve as the primary liaison to the company's Medical Advisory Board. Most recently, he was Director of Research and Development at Formatech.
News For BTHE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2014
08:43 EDTBTHEBoston Therapeutics reports topline BTI-320 Phase IIb study results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use